240 related articles for article (PubMed ID: 28558662)
1. Evaluation of gene xpert for routine diagnosis of HIV-associated tuberculosis in Nigeria: A prospective cohort study.
Akanbi MO; Achenbach C; Taiwo B; Idoko J; Ani A; Isa Y; Agbaji O; Ukoli C; Akande P; Maiga M; Murphy RL
BMC Pulm Med; 2017 May; 17(1):87. PubMed ID: 28558662
[TBL] [Abstract][Full Text] [Related]
2. Tuberculosis treatment outcomes among people living with HIV diagnosed using Xpert MTB/RIF versus sputum-smear microscopy in Botswana: a stepped-wedge cluster randomised trial.
Agizew T; Chihota V; Nyirenda S; Tedla Z; Auld AF; Mathebula U; Mathoma A; Boyd R; Date A; Pals SL; Lekone P; Finlay A
BMC Infect Dis; 2019 Dec; 19(1):1058. PubMed ID: 31842773
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study.
Scott LE; McCarthy K; Gous N; Nduna M; Van Rie A; Sanne I; Venter WF; Duse A; Stevens W
PLoS Med; 2011 Jul; 8(7):e1001061. PubMed ID: 21814495
[TBL] [Abstract][Full Text] [Related]
4. Chest X-ray interpretation does not complement Xpert MTB/RIF in diagnosis of smear-negative pulmonary tuberculosis among TB-HIV co-infected adults in a resource-limited setting.
Nakiyingi L; Bwanika JM; Ssengooba W; Mubiru F; Nakanjako D; Joloba ML; Mayanja-Kizza H; Manabe YC
BMC Infect Dis; 2021 Jan; 21(1):63. PubMed ID: 33435896
[TBL] [Abstract][Full Text] [Related]
5. Time to treatment and patient outcomes among TB suspects screened by a single point-of-care xpert MTB/RIF at a primary care clinic in Johannesburg, South Africa.
Hanrahan CF; Selibas K; Deery CB; Dansey H; Clouse K; Bassett J; Scott L; Stevens W; Sanne I; Van Rie A
PLoS One; 2013; 8(6):e65421. PubMed ID: 23762367
[TBL] [Abstract][Full Text] [Related]
6. Real-Life Clinical Practice of Using the Xpert MTB/RIF Assay in Thailand.
Kawkitinarong K; Suwanpimolkul G; Kateruttanakul P; Manosuthi W; Ubolyam S; Sophonphan J; Avihingsanon A; Ruxrungtham K
Clin Infect Dis; 2017 May; 64(suppl_2):S171-S178. PubMed ID: 28475796
[TBL] [Abstract][Full Text] [Related]
7. Effect of Xpert MTB/RIF on clinical outcomes in routine care settings: individual patient data meta-analysis.
Di Tanna GL; Khaki AR; Theron G; McCarthy K; Cox H; Mupfumi L; Trajman A; Zijenah LS; Mason P; Bandason T; Durovni B; Bara W; Hoelscher M; Clowes P; Mangu C; Chanda D; Pym A; Mwaba P; Cobelens F; Nicol MP; Dheda K; Churchyard G; Fielding K; Metcalfe JZ
Lancet Glob Health; 2019 Feb; 7(2):e191-e199. PubMed ID: 30683238
[TBL] [Abstract][Full Text] [Related]
8. Comparing rates of mycobacterial clearance in sputum smear-negative and smear-positive adults living with HIV.
Machowski EE; Letutu M; Lebina L; Waja Z; Msandiwa R; Milovanovic M; Gordhan BG; Otwombe K; Friedrich SO; Chaisson R; Diacon AH; Kana B; Martinson N
BMC Infect Dis; 2021 May; 21(1):466. PubMed ID: 34022850
[TBL] [Abstract][Full Text] [Related]
9. Baseline Xpert MTB/RIF ct values predict sputum conversion during the intensive phase of anti-TB treatment in HIV infected patients in Kampala, Uganda: a retrospective study.
Namugenyi J; Musaazi J; Katamba A; Kalyango J; Sendaula E; Kambugu A; Fehr J; Castelnouvo B; Manabe YC; Ssengooba W; Sekaggya-Wiltshire C
BMC Infect Dis; 2021 Jun; 21(1):513. PubMed ID: 34074248
[TBL] [Abstract][Full Text] [Related]
10. Effect of the Xpert MTB/RIF on the detection of pulmonary tuberculosis cases and rifampicin resistance in Shanghai, China.
Wu Z; Rueda ZV; Li T; Zhang Z; Jiang Y; Sha W; Yu F; Chen J; Pan Q; Shen X; Yuan Z
BMC Infect Dis; 2020 Feb; 20(1):153. PubMed ID: 32070292
[TBL] [Abstract][Full Text] [Related]
11. Enhancing TB case detection: experience in offering upfront Xpert MTB/RIF testing to pediatric presumptive TB and DR TB cases for early rapid diagnosis of drug sensitive and drug resistant TB.
Raizada N; Sachdeva KS; Nair SA; Kulsange S; Gupta RS; Thakur R; Parmar M; Gray C; Ramachandran R; Vadera B; Ekka S; Dhawan S; Babre A; Ghedia M; Alavadi U; Dewan P; Khetrapal M; Khanna A; Boehme C; Paramsivan CN
PLoS One; 2014; 9(8):e105346. PubMed ID: 25140877
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Xpert MTB/RIF assay in children with presumed pulmonary tuberculosis in Papua New Guinea.
Kasa Tom S; Welch H; Kilalang C; Tefuarani N; Vince J; Lavu E; Johnson K; Magaye R; Duke T
Paediatr Int Child Health; 2018 May; 38(2):97-105. PubMed ID: 28490246
[TBL] [Abstract][Full Text] [Related]
13. Intensified tuberculosis case-finding in HIV-positive adults managed at Ethiopian health centers: diagnostic yield of Xpert MTB/RIF compared with smear microscopy and liquid culture.
Balcha TT; Sturegård E; Winqvist N; Skogmar S; Reepalu A; Jemal ZH; Tibesso G; Schön T; Björkman P
PLoS One; 2014; 9(1):e85478. PubMed ID: 24465572
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of a clinical diagnostic algorithm for management of ambulatory smear and Xpert MTB/Rif negative HIV infected patients with presumptive pulmonary TB in Uganda: a prospective study.
Walusimbi S; Semitala F; Bwanga F; Haile M; De Costa A; Davis L; Joloba M; Hoffner S; Kamya M
Pan Afr Med J; 2016; 23():154. PubMed ID: 27303572
[TBL] [Abstract][Full Text] [Related]
15. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.
Steingart KR; Schiller I; Horne DJ; Pai M; Boehme CC; Dendukuri N
Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD009593. PubMed ID: 24448973
[TBL] [Abstract][Full Text] [Related]
16. The effect of the Xpert MTB/RIF test on the time to MDR-TB treatment initiation in a rural setting: a cohort study in South Africa's Eastern Cape Province.
Iruedo J; O'Mahony D; Mabunda S; Wright G; Cawe B
BMC Infect Dis; 2017 Jan; 17(1):91. PubMed ID: 28109255
[TBL] [Abstract][Full Text] [Related]
17. Clinical and CT characteristics of Xpert MTB/RIF-negative pulmonary tuberculosis.
Lee HN; Kim JI; Kim YH
PLoS One; 2021; 16(5):e0250616. PubMed ID: 33939723
[TBL] [Abstract][Full Text] [Related]
18. Improved performance of Xpert MTB/RIF assay on sputum sediment samples obtained from presumptive pulmonary tuberculosis cases at Kibong'oto infectious diseases hospital in Tanzania.
Mbelele PM; Aboud S; Mpagama SG; Matee MI
BMC Infect Dis; 2017 Dec; 17(1):808. PubMed ID: 29284421
[TBL] [Abstract][Full Text] [Related]
19. Burden of tuberculosis in intensive care units in Cape Town, South Africa, and assessment of the accuracy and effect on patient outcomes of the Xpert MTB/RIF test on tracheal aspirate samples for diagnosis of pulmonary tuberculosis: a prospective burden of disease study with a nested randomised controlled trial.
Calligaro GL; Theron G; Khalfey H; Peter J; Meldau R; Matinyenya B; Davids M; Smith L; Pooran A; Lesosky M; Esmail A; Miller MG; Piercy J; Michell L; Dawson R; Raine RI; Joubert I; Dheda K
Lancet Respir Med; 2015 Aug; 3(8):621-30. PubMed ID: 26208996
[TBL] [Abstract][Full Text] [Related]
20. Retrospective Diagnostic Accuracy Study of Abbott RealTi
Howlett P; Nabeta P; Tukvadze N; Schumacher SG; Denkinger CM
Microbiol Spectr; 2021 Sep; 9(1):e0013221. PubMed ID: 34406811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
